NS Partners Ltd bought a new position in shares of Oracle Corporation (NYSE:ORCL – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 59,674 shares of the enterprise software provider’s stock, valued at approximately $8,745,000.
Several other hedge funds also recently made changes to their positions in ORCL. HFM Investment Advisors LLC increased its position in shares of Oracle by 290.9% during the fourth quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock valued at $25,000 after buying an additional 96 shares during the period. Basepoint Wealth LLC purchased a new position in Oracle during the fourth quarter valued at approximately $26,000. FSA Wealth Management LLC bought a new stake in Oracle during the 3rd quarter worth approximately $28,000. Osbon Capital Management LLC purchased a new stake in Oracle in the 4th quarter worth approximately $28,000. Finally, Basso Capital Management L.P. purchased a new position in shares of Oracle during the 4th quarter valued at $29,000. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
Oracle Stock Performance
Shares of NYSE ORCL opened at $149.43 on Tuesday. The stock’s 50-day moving average is $140.21 and its 200 day moving average is $160.55. The stock has a market cap of $430.43 billion, a price-to-earnings ratio of 25.63, a P/E/G ratio of 0.94 and a beta of 1.72. Oracle Corporation has a 1-year low of $114.50 and a 1-year high of $345.72. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 3.21.
Oracle Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Friday, July 10th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.3%. The ex-dividend date was Friday, July 10th. Oracle’s dividend payout ratio is presently 34.31%.
Oracle News Summary
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle’s AI opportunity remains a major potential catalyst. One analysis highlights the company’s large AI-related bookings and its position as a beneficiary of Nvidia’s expanding technology ecosystem, while another reports that Erste Group Bank raised its FY2028 EPS estimates. Nvidia Changes Everything, Says Top Investor About Oracle Stock FY2028 EPS Estimates for Oracle Boosted by Erste Group Bank
- Positive Sentiment: Oracle Health is expanding its Clinical AI Agent in the United States to support professional-fee coding, real-time dictation and chart review. Integrating these tools with Oracle’s cloud and AI stack could strengthen its role in mission-critical healthcare systems and support longer-term cloud growth. Is Oracle Using Healthcare AI to Quietly Redefine Its Core Cloud Strategy?
- Neutral Sentiment: Oracle was identified as a key vendor in blockchain and 5G-edge technology, and was included among suppliers expected to benefit from growth in the inventory-control software market. These reports point to addressable-market opportunities but do not provide a new financial forecast or contract announcement. Oracle Is Named a Key Vendor in Blockchain and 5G Edge
- Negative Sentiment: Investors remain concerned that Oracle’s spending to build AI capacity will arrive before the associated revenue. Record bookings may take time to convert into sales, potentially pressuring cash flow, margins and near-term earnings. The Bill for Oracle’s AI Build Arrived Before the Revenue
- Negative Sentiment: Commentary describing Oracle as a potential chronic underperformer, along with comparisons showing weakness versus the broader market, added to the cautious tone. The company’s upcoming earnings report is therefore viewed as an important catalyst capable of producing a sizable move. Oracle May Remain a Chronic Underperformer Oracle at a Crossroads: Big Earnings Could Trigger a Massive Swing
Wall Street Analyst Weigh In
ORCL has been the topic of a number of recent analyst reports. Barclays increased their price objective on Oracle from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Thursday, June 11th. Citigroup reaffirmed a “buy” rating on shares of Oracle in a report on Wednesday, August 26th. Evercore reissued an “outperform” rating and set a $245.00 price objective on shares of Oracle in a report on Monday, June 8th. Wolfe Research restated an “outperform” rating and issued a $225.00 price objective on shares of Oracle in a research report on Thursday, June 11th. Finally, Oppenheimer boosted their price target on shares of Oracle from $235.00 to $275.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $263.97.
Check Out Our Latest Analysis on ORCL
Insider Activity
In other news, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total value of $63,664,000.00. Following the transaction, the insider owned 400,000 shares in the company, valued at approximately $63,664,000. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 40.90% of the company’s stock.
Oracle Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
See Also
- Five stocks we like better than Oracle
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
